Throne Equity Crowdfunding

04/23/2022

7 Days Left to Invest at the Throne’s Campaign: We are so thankful for all of our investors so far and sincerely appreciate all your generosities to support the clinical trials of Stem Cell Educator therapy to treat type 1 diabetes and alopecia areata through this campaign at StartEngine. We are happy to announce that we are going to start these clinical trials in June, about two months away from now. Throne’s equity crowdfunding campaign will be closed soon on April 30th. We look forward to the growth that would not be possible without your investment. Visit our page at https://www.startengine.com/throne-biotechnologies to invest.

Find a cure type 1 diabetes, alopecia areata, and other autoimmune diseases

03/31/2022

Alopecia areata (AA) is one of the most common autoimmune diseases that results in loss of body hair such as alopecia totalis (AT, total loss of scalp hair) and alopecia universalis (AU, complete loss of body hair). AA is a serious condition with physical, emotional and social impacts, having an unmet need. To date, there are no FDA-approved drugs for AA. Notably, Dr. Zhao and his team demonstrated the clinical efficacy of Stem Cell Educator therapy for the treatment of alopecia patients (see the following image, for more information see the publication Li Y, et al. BMC Medicine 2015).

Currently, Throne has received the FDA approval for phase 2 clinical trial of Educator therapy to treat AA subjects through the collaboration with the renowned dermatologist Dr. Brett King at Yale University. It is highly expected that Stem Cell Educator therapy will achieve an expedited FDA approval under the designation of Regenerative Medicine Advanced Therapy (RMAT) due to an unmet medical need for AA. We need your support to facilitate the clinical transition of Stem Cell Educator therapy into a practical care. Please visit the Throne campaign page to learn more and invest on StartEngine: https://www.startengine.com/throne-biotechnologies

03/28/2022

Practical cure of type 1 diabetes, alopecia areata, and other autoimmune diseases by the Stem Cell Educator therapy

03/25/2022

Throne Award: One of the "5 Best BioTech Companies To Watch" by The Silicon Review

Google Drive is a free way to keep your files backed up and easy to reach from any phone, tablet, or computer. Start with 15GB of Google storage – free.

03/22/2022

03/22/2022

03/22/2022

03/21/2022

Throne Biotechnologies (Throne) is one of the global-leading biotech companies aiming to achieve the FDA approval on the Stem Cell Educator therapy and find a cure for type 1 diabetes, alopecia areata and other autoimmune diseases. Stem Cell Educator therapy — a one-time, dialysis-like treatment that fundamentally “re-educates” the defective immune system back to health. Those interested in facilitating the clinical transition of Stem Cell Educator therapy can visit the Throne crowdfunding campaign page to learn more and invest on StartEngine: https://www.startengine.com/throne-biotechnologies

03/21/2022